1. |
Jalink MB, Bronkhorst IHG. A sudden rise of patients with acute macular neuroretinopathy during the COVID-19 pandemic[J]. Case Rep Ophthalmol, 2022, 13(1): 96-103. DOI: 10.1159/000522080.
|
2. |
Azar G, Bonnin S, Vasseur V, et al. Did the COVID-19 pandemic increase the incidence of acute macular neuroretinopathy?[J]. J Clin Med, 2021, 10(21): 5038. DOI: 10.3390/jcm10215038.
|
3. |
Feigl B, Haas A. Optical coherence tomography (OCT) in acute macular neuroretinopathy[J]. Acta Ophthalmol Scand, 2000, 78(6): 714-716. DOI: 10.1034/j.1600-0420.2000.078006714.x.
|
4. |
Fawzi AA, Pappuru RR, Sarraf D, et al. Acute macular neuroretinopathy: long-term insights revealed by multimodal imaging[J]. Retina, 2012, 32(8): 1500-1513. DOI: 10.1097/IAE.0b013e318263d0c3.
|
5. |
Sarraf D, Rahimy E, Fawzi AA, et al. Paracentral acute middle maculopathy: a new variant of acute macular neuroretinopathy associated with retinal capillary ischemia[J]. JAMA Ophthalmol, 2013, 131(10): 1275-1287. DOI: 10.1001/jamaophthalmol.2013.4056.
|
6. |
D'Souza HS, Tailor PD, Olsen TW. Seeing blue dots after COVID-19 infection[J]. JAMA Ophthalmol, 2023, 141(1): 97-98. DOI: 10.1001/jamaophthalmol.2022.5235.
|
7. |
Bhavsar KV, Lin S, Rahimy E, et al. Acute macular neuroretinopathy: a comprehensive review of the literature[J]. Surv Ophthalmol, 2016, 61(5): 538-565. DOI: 10.1016/j.survophthal.2016.03.003.
|
8. |
滕岩, 滕羽菲. 急性黄斑区神经视网膜病变的临床特征及病理机制研究进展[J]. 中华眼科杂志, 2019, 55(4): 311-315. DOI: 10.3760/cma.j.issn.0412-4081.2019.04.016.Teng Y, Teng YF. The clinical characteristics and pathologic mechanisms of acute macular neuroretinopathy[J]. Chin J Ophthal, 2019, 55(4): 311-315. DOI: 10.3760/cma.j.issn.0412-4081.2019.04.016.
|
9. |
李梦洋, 钱彤, 黎晓新, 等. 急性黄斑旁中心中层视网膜病变患眼临床特征及多模式影像特征观察[J]. 中华眼底病杂志, 2019, 35(4): 322-326. DOI: 10.3760/cma.j.issn.1005-1015.2019.04.002.Li MY, Qian T, Li XX, et al. The clinical and multimodal imaging characteristics of paracentral acute middle maculopathy[J]. Chin J Ocul Fundus Dis, 2019, 35(4): 322-326. DOI: 10.3760/cma.j.issn.1005-1015.2019.04.002.
|
10. |
Ashfaq I, Vrahimi M, Waugh S, et al. Acute macular neuroretinopathy associated with acute influenza virus infection[J]. Ocul Immunol Inflamm, 2021, 29(2): 333-339. DOI: 10.1080/09273948.2019.1681470.
|
11. |
Walls AC, Park YJ, Tortorici MA, et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein[J]. Cell, 2020, 181(2): 281-292. DOI: 10.1016/j.cell.2020.02.058.
|
12. |
Senanayake PD, Drazba J, Shadrach K, et al. Angiotensin Ⅱ and its receptor subtypes in the human retina[J]. Invest Ophthalmol Vis Sci, 2007, 48(7): 3301-3311. DOI: 10.1167/iovs.06-1024.
|
13. |
Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19[J]. Nat Med, 2020, 26(7): 1017-1032. DOI: 10.1038/s41591-020-0968-3.
|
14. |
David JA, Fivgas GD. Acute macular neuroretinopathy associated with COVID-19 infection[J/OL]. Am J Ophthalmol Case Rep, 2021, 24: 101232[2021-11-10]. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577875/. DOI: 10.1016/j.ajoc.2021.101232.
|
15. |
Gaba WH, Ahmed D, Al Nuaimi RK, et al. Bilateral central retinal vein occlusion in a 40-year-old man with severe coronavirus disease 2019 (COVID-19) pneumonia[J/OL]. Am J Case Rep, 2020, 21: e927691[2020-10-29]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603800/. DOI: 10.12659/AJCR.927691.
|
16. |
Yeo S, Kim H, Lee J, et al. Retinal vascular occlusions in COVID-19 infection and vaccination: a literature review[J/OL]. Graefe's Arch Clin Exp Ophthalmol, 2023: 1-16[2023-01-04]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811047/. DOI: 10.1007/s00417-022-05953-7.
|
17. |
Turbeville SD, Cowan LD, Gass JD. Acute macular neuroretinopathy: a review of the literature[J]. Surv Ophthalmol, 2003, 48(1): 1-11. DOI: 10.1016/s0039-6257(02)00398-3.
|